Alarcon-Segovia D., Ramos-Niembro F., Kasep G. et al. Longterm evaluation of colchicine in the treatment of scleroderma. — J. rheumatol., 1979, 6, 705.
Cannon P. J. Medical management of renal scleroderma — New Engl. J. Med., 1978, 299, 886.
Davis P., Bleehen S. S. Dpenicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis. — Brit. J. Dermatol., 1976, 94 (6), 705.
Fleischmajer R. Discussion of paper: Methodology and techniques in the evaluation of dimethyl sulfoxide for connective tissue disorders. — Ann. N. Y. Acad. Sci., 1975, 243, 393.
Guttadauria M., Diamond H., Kaplan D. Colchicine in the treatment of scleroderma. (Abstract). ARA National Meeting, December N 9, 1976.
Le Roy E. C., Downey J. A., Cannon P. J. Skin capillary blood flow in scleroderma. — J. Clin. Investigation, 1971, 50, 930.
Lopez-Ovejero J. A., Saal S. D., D Angelo W. A. Reversal of vascular and renal crisis of scleroderma by oral angiotensin converting enzyme blockade. — New Engl. J. Med., 1979, 300, 1417.
Pettinger W. A., Mitchell H. C. Minoxidil — an alternative to nephrectomy for refractory hypertension. — New Engl. J. Med., 1973, 289, 167.
Shigemi F., Fujita Т., Oshaki M., Shiraishi S. Fibrinolytic therapy for progressive systemic sclerosis and tissue fibrinolytic activity in affected skin. — J. Dermatol., 1978, 5, 135.
Tuffanelli D. L. A clinical trial with dimethylsulfoxide in scleroderma. — Arr.h, Dermatol. (Chicago), 1966, 93, 724.
Varadi D. P., Lawrence A. M. Suppression of Raynauds phenomenon by methyldopa. — Arch, intern. Med., 1969, 124. 13.
Winkelmann R. K., Kierland R. R., Perry H. D et al. Management of scleroderma. Mayo Clin. Proc, 1971, 46, 128.
«Лечение ревматических заболеваний»,
под ред. Ф.Д.Харта